Monica Agarwal MD, MEHP, FACE, provides her perspectives on the recent FDA approval of Semaglutide as an addition to the therapeutic armamentarium of weight management options for people living with obesity. Learn her key takeaways and how the new injectable semaglutide can support adults living with obesity.
April 1, 2021
We're seeking volunteers to update the 2016 Clinical Practice Guidelines for the Medical Care of Patients with Obesity. Volunteer now!
The U.S. Food and Drug Administration has updated the Nutrition Facts label.
August 18, 2020 (Latest Update)
AACE is closely monitoring developments regarding COVID-19 and working with partner medical societies to provide information and resources to our members. Click to view COVID-19 resources, including more about navigating telehealth services.
Coinciding with World Obesity Day, AACE has joined over 100 medical and scientific organizations across the world in pledging our support for a consensus statement that recognizes unscientific public narratives of obesity as a major cause of weight stigma and calls for strong policies and legislation to prevent weight-based discrimination.
November 4, 2019
AACE has released updated guidelines for the perioperative nutrition, metabolic and nonsurgical support of patients undergoing bariatric procedures.
August 12, 2019
The Government Accountability Office (GAO) has released a new study on prescription drug use to treat obesity.
Presenting PrescriptionHelp.aace.com – A directory of prescription affordability programs and resources for your endocrine patients to help them acquire the medications they need at reduced out-of-pocket costs.
Lower income and education levels may negatively affect the experience and expectations of patients who are obese who receive care for weight management, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.